Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Brinkmann

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Immunity|March 1, 1995
Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structureY Reiter, I Kurucz, U Brinkmann, et al.
Lancet (London, England)|August 15, 2001
Frequency of C3435T polymorphism of MDR1 gene in African peopleE Schaeffeler, M Eichelbaum, U Brinkmann, et al.
Anticancer Research|August 6, 2000
Proliferative activity in the progression of pigmented skin lesions, diagnostic and prognostic significanceM Korabiowska, U Brinck, P Middel, et al.
The Journal of Biological Chemistry|July 15, 1994
Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragmentY Reiter, U Brinkmann, S H Jung, et al.
Water Research|September 9, 2023
Molecular-scale characterization of groundwater treatment sludge from around the world: Implications for potential arsenic recoveryK Wang, P E Holm, U Brinkmann Trettenes, et al.
International Journal of Cancer|May 16, 1997
Cloning and expression of the recombinant FAb fragment of monoclonal antibody K1 that reacts with mesothelin present on mesotheliomas and ovarian cancersU Brinkmann, K Webber, A Di Carlo, et al.
Clinical Pharmacology and Therapeutics|March 10, 2001
Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjectsI Cascorbi, T Gerloff, A Johne, et al.
Annales De Biologie Clinique|June 14, 2003
[A new, rapid and robust genotyping method for CYP2C9 and MDR1]C Verstuyft, S Morin, J Yang, et al.
International Journal of Obesity (2005)|June 16, 2010
LIGHT (TNFSF14) inhibits adipose differentiation without affecting adipocyte metabolismG Tiller, H Laumen, P Fischer-Posovszky, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4E Hustert, A Zibat, E Presecan-Siedel, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Immunity|March 1, 1995
Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structureY Reiter, I Kurucz, U Brinkmann, et al.
Lancet (London, England)|August 15, 2001
Frequency of C3435T polymorphism of MDR1 gene in African peopleE Schaeffeler, M Eichelbaum, U Brinkmann, et al.
Anticancer Research|August 6, 2000
Proliferative activity in the progression of pigmented skin lesions, diagnostic and prognostic significanceM Korabiowska, U Brinck, P Middel, et al.
The Journal of Biological Chemistry|July 15, 1994
Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragmentY Reiter, U Brinkmann, S H Jung, et al.
Water Research|September 9, 2023
Molecular-scale characterization of groundwater treatment sludge from around the world: Implications for potential arsenic recoveryK Wang, P E Holm, U Brinkmann Trettenes, et al.
International Journal of Cancer|May 16, 1997
Cloning and expression of the recombinant FAb fragment of monoclonal antibody K1 that reacts with mesothelin present on mesotheliomas and ovarian cancersU Brinkmann, K Webber, A Di Carlo, et al.
Clinical Pharmacology and Therapeutics|March 10, 2001
Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjectsI Cascorbi, T Gerloff, A Johne, et al.
Annales De Biologie Clinique|June 14, 2003
[A new, rapid and robust genotyping method for CYP2C9 and MDR1]C Verstuyft, S Morin, J Yang, et al.
International Journal of Obesity (2005)|June 16, 2010
LIGHT (TNFSF14) inhibits adipose differentiation without affecting adipocyte metabolismG Tiller, H Laumen, P Fischer-Posovszky, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4E Hustert, A Zibat, E Presecan-Siedel, et al.
Pageof 10